Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (60 ops.)
Latest filing published 01 Jul 2026 for Stereotaxis, Inc..
Filing timeline
BuySaleMyriam Curet
Insider track record
Disclosed buys
2
Disclosed sells
60
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-55.3%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -55.3%Entry US$130.39 · Close at T+90 US$58.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Myriam Curet: trading record in brief
In the record of Myriam Curet, option exercises (61) outweigh everything else: of 162 filings, they come ahead of 38 grants, 59 sales, 2 purchases and 2 other filing. The 59 sales amount to EUR 46.8 million, median EUR 546,900. The three largest are dated September 9, 2021 (EUR 2,746,187), November 12, 2024 (EUR 2,512,848) and October 28, 2025 (EUR 2,367,543), all at Intuitive Surgical Inc.
The only purchase is EUR 601, on March 20, 2025 at Inspire Medical Systems, Inc.; it is 3% of the open-market trades.
Four US companies appear: Intuitive Surgical Inc (140 filings, EVP & Chief Medical Officer), Stereotaxis, Inc. (10, Director), Inspire Medical Systems, Inc. (7, Director) and Nektar Therapeutics (5, Director). The trades run from September 9, 2021 to July 1, 2026, with 8 filings in 2021 and between 27 and 38 in the following years.
Filings appear quickly, a median of 1 day after the trade. 45 filings fall in the last twelve months, including the purchase and 18 sales.
Companies and markets linked to Myriam Curet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations162 total
43,103 sharesCommon StockSEC:0001493152-26-031533:0
105 shares@ US$493.950.1% of flowCommon StockSEC:0001632901-26-000014:1
105 shares@ US$229.390.2% of flowCommon StockSEC:0001632901-26-000014:0
125 shares@ US$492.590.1% of flowCommon StockSEC:0001632901-26-000012:1
4,728 shares@ US$487.182.7% of flowCommon StockSEC:0001632901-26-000012:2
125 shares@ US$208.900.2% of flowCommon StockSEC:0001632901-26-000012:0
1,002 shares0Common StockSEC:0001632901-26-000010:1
8,378 shares0Common StockSEC:0001632901-26-000010:3
497 shares@ US$503.510.3% of flowCommon StockSEC:0001632901-26-000010:2
4,155 shares@ US$503.512.4% of flowCommon StockSEC:0001632901-26-000010:4
2,345 shares@ US$499.718.2% of flowCommon StockSEC:0001632901-26-000010:0
1,602 shares0Common StockSEC:0001632901-26-000008:2
1,514 shares@ US$506.170.9% of flowCommon StockSEC:0001632901-26-000008:1
795 shares@ US$506.170.5% of flowCommon StockSEC:0001632901-26-000008:3
3,052 shares0Common StockSEC:0001632901-26-000008:0
417 shares@ US$492.840.2% of flowCommon StockSEC:0001632901-26-000006:1
105 shares@ US$229.390.0% of flowCommon StockSEC:0001632901-26-000006:2
105 shares@ US$494.650.1% of flowCommon StockSEC:0001632901-26-000006:3
421 shares@ US$494.960.2% of flowCommon StockSEC:0001632901-26-000006:4
838 shares0Common StockSEC:0001632901-26-000006:0
126 shares@ US$520.020.1% of flowCommon StockSEC:0001632901-26-000004:1
126 shares@ US$208.900.2% of flowCommon StockSEC:0001632901-26-000004:0
105 shares@ US$532.610.1% of flowCommon StockSEC:0001632901-26-000002:1
125 shares@ US$208.900.0% of flowCommon StockSEC:0001632901-26-000002:2
125 shares@ US$532.610.1% of flowCommon StockSEC:0001632901-26-000002:3
25 of 162 declarations
